BBLU EA Bridgeway Blue Chip ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| XOM | 3.87% |
| JPM | 3.78% |
| NVDA | 3.74% |
| CVX | 3.74% |
| AVGO | 3.69% |
| AAPL | 3.40% |
| VZ | 3.32% |
| JNJ | 3.16% |
| AMD | 3.15% |
| COST | 3.10% |
ETF Analysis
Fund Overview
EA Bridgeway Blue Chip ETF (BBLU) currently reports 37 stock positions (subject to change), placing it in the neither concentrated nor index-like range by holdings breadth. The top line-up is XOM (3.87%), JPM (3.78%), NVDA (3.74%), with XOM as the largest single weight at 3.87%. Together, the top three holdings account for 11.39%, which indicates that idiosyncratic risk at the top of the book is relatively contained within the overall portfolio. The resulting profile combines thematic conviction with varying degrees of diversification, which can support upside participation while still spreading idiosyncratic risk beyond the top weights.
Profitability & Capital Efficiency
From a returns-on-capital standpoint, ROIC is 35.06%, WACC is 8.40%, and the economic spread is 26.65%. On balance, the gap between ROIC and WACC places this portfolio among the more capital-efficient baskets available. Supporting metrics show ROE at 42.40% and ROA at 12.06%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.
Valuation
The market currently prices the portfolio at trailing P/E of 26.07, forward P/E of 20.95, PEG of 2.12. The trailing and forward multiples diverge by a moderate amount, consistent with a market that sees improving earnings but is not extrapolating an aggressive growth path. The PEG ratio is consistent with a portfolio that is reasonably valued on a growth basis — not cheap, but not obviously expensive either. The aggregate current ratio of 1.53 points to adequate liquidity across holdings. Valuation and liquidity together frame a portfolio where the price paid today is a reasonable bet on earnings delivery — but not a margin-of-safety purchase at current levels.
Margins & Cash Generation
On profitability at each income statement layer, gross margin sits at 56.08%, operating margin at 28.75%, and free cash flow margin at 20.17%. The portfolio's gross margins are solid, reflecting a reasonable balance between revenue realization and direct cost absorption. At this operating margin level, the holdings demonstrate competent cost management and reasonable earnings durability. Free cash flow margins are strong, reflecting capital-efficient businesses that largely self-fund their growth. Across all three layers, the margin stack points to a high-quality portfolio with durable unit economics and strong cash generation capacity.
Growth & Forward Outlook
Looking at growth and market-implied direction, TTM revenue growth of 15.29% indicating top-line growth that is constructive without being speculative. At the same time, the estimated 12-month price change of 20.27%, where implied upside appears constructive but not aggressive. It's worth distinguishing between what businesses are actually delivering and what the market is being asked to believe about the next 12 months. Maintaining alignment between reported results and forward estimates is particularly important in periods where macro uncertainty is elevated. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
Strong BuyThe composite of ROIC spread, valuation, revenue momentum, and analyst expectations delivers a rare alignment of quality and growth that justifies elevated conviction.
The views expressed above are derived from quantitative data only and should not be relied upon as financial advice. Investment decisions should be based on your own research and risk tolerance.